目　录 1　输血和血液管理的历史 ·········································································································1 2　现代血库 ··························································································································11 3　血液成分治疗 ··················································································································· 21 4　凝血系统和血凝块稳定性 ···································································································· 29 5　纤维蛋白溶解、抗纤维蛋白溶解药物及围手术期应用 ································································ 37 6　血液高凝与血栓性疾病 ······································································································· 51 7　血小板异常情况或疾病 ······································································································· 57 8　大量输血方案 ··················································································································· 69 9　辅助凝血的新生物制剂 ······································································································· 81 10　影响止血的草药··············································································································· 89 11　出血性疾病的超声检查 ·····································································································101 12　输血并发症···················································································································· 113 13　凝血系统疾病：血友病、血管性血友病、冷球蛋白血症和先天性凝血因子合成障碍 ······················ 119 14　血液保护策略和免输血医学 ······························································································127 15　当不能选择输血时：对耶和华见证会信徒患者的管理 ·····························································133 16　血液替代品与人工氧载体 ·································································································139 17　贫血的术前治疗··············································································································143 18　自然灾难和军事战争中血液制品管理 ··················································································151 19　影响凝血的常用处方药：综述 ···························································································165 20　严重创伤患者的输血 ·······································································································189 21　围手术期凝血床旁检测 ····································································································199 22　血管内皮功能障碍与炎症状态 ···························································································213 23　产科患者血液管理 ··········································································································229 24　儿科患者血液管理 ··········································································································239 25　肝移植患者的血液管理 ····································································································255 26　开放性与保守性输血策略 ·································································································265 27　遗传性凝血功能障碍 ·······································································································275 2 麻醉实践中血液制品管理精要 28　铁过载的代谢、病理生理学及临床治疗 ···············································································285 29　输血治疗的陷阱··············································································································297 30　创伤性颅脑损伤与输血 ····································································································309 31　输血相关免疫调节与围手术期感染 / 肿瘤复发：输血相关的生理改变、证据和争议 ·······················317 32　血液制品的来源··············································································································325 33　心脏外科的血液保护与管理 ······························································································331 34　富血小板血浆：不只是运动员的福音 ··················································································337 35　烧伤患者的输血治疗 ·······································································································345 36　院前急救输血·················································································································349 37　全血又回来了·················································································································361 38　生理盐水：对于出血患者并不够生理 ··················································································367 39　老年患者的血液管理 ·······································································································371 40　药物滥用和凝血功能障碍 ·································································································379 41　围手术期输注异体血液制品对癌症复发的影响 ······································································387 42　红细胞增多症的围手术期处理 ···························································································393 43　早产儿的血液管理 ··········································································································399 44　凝血与区域麻醉·············································································································· 411 45　铁过载··························································································································421 46　发展中国家的血液制品管理 ······························································································425 47　接受介入性疼痛管理的患者使用抗凝和抗血栓药物的注意事项和指南 ········································429 48　红细胞的储存损伤：生物学与随机对照试验的争论 ································································441 彩图···································································································································45